Zosyn and Macrobid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zosyn (piperacillin sodium; tazobactam sodium) and Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline). Common drug interactions include sensation of pressure among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Zosyn and Macrobid. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Zosyn?

Zosyn has active ingredients of piperacillin sodium; tazobactam sodium. It is often used in pneumonia. eHealthMe is studying from 10,236 Zosyn users. Check the latest studies of Zosyn.

What is Macrobid?

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 9,215 Macrobid users. Check the latest studies of Macrobid.



On Jul, 18, 2026

43 people who take Zosyn and Macrobid together, and have interactions are studied.

Zosyn and Macrobid drug interactions.

What are the common drug interactions of Zosyn and Macrobid, by gender? *:

female:

  1. Sensation of pressure
  2. Swelling face
  3. Traumatic haematoma (a blood clot in body due to trauma)
  4. Vomiting
  5. Anaemia (lack of blood)
  6. Anastomotic leak
  7. Anxiety
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Faecaloma (hard mass of fecal matter)
  10. Ureteric obstruction

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Aortic arteriosclerosis (hardening of the aortic arteries)
  3. Gait disturbance
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Hypertension (high blood pressure)
  7. Hypokalaemia (low potassium)
  8. Hypotension (abnormally low blood pressure)
  9. Injury
  10. Memory impairment

What are the common drug interactions of Zosyn and Macrobid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Nephrolithiasis (calculi in the kidneys)

20-29:

n/a

30-39:

  1. Anal abscess
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Arterial thrombosis limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb)
  5. Cellulitis (infection under the skin)
  6. Cholecystitis (infection of gallbladder)
  7. Emotional distress
  8. Gallbladder injury
  9. General physical health deterioration (weak health status)
  10. Genital abscess (build up of pus in genital)

40-49:

  1. Arthralgia (joint pain)
  2. Benign neoplasm of thyroid gland (benign (non-cancerous) tumours of the thyroid gland)
  3. Bone disorder
  4. Colon neoplasm (cancer from uncontrolled cell growth in the colon or rectum)
  5. Decreased interest
  6. Defaecation urgency (a sudden compelling urge to defecate)
  7. Depression
  8. Dysfunctional uterine bleeding
  9. Dyspnoea (difficult or laboured respiration)
  10. Emotional distress

50-59:

  1. Aspartate aminotransferase increased
  2. Diarrhoea
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Nausea (feeling of having an urge to vomit)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Vomiting
  7. Chronic kidney disease
  8. Renal failure (kidney dysfunction)
  9. Renal tubular necrosis (death of kidney tubules)
  10. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Headache (pain in head)
  5. Hypertension (high blood pressure)
  6. Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
  7. Respiratory tract infection bacterial
  8. Asthenia (weakness)
  9. Back pain
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 23.26%
  2. Diarrhea: 9 people, 20.93%
  3. Metastases To Bone (cancer spreads to bone): 7 people, 16.28%
  4. High Blood Pressure: 7 people, 16.28%
  5. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 6 people, 13.95%
  6. Hiv Infection: 6 people, 13.95%
  7. Depression: 6 people, 13.95%
  8. Asthma: 6 people, 13.95%
  9. Respiratory Tract Infection Viral: 5 people, 11.63%
  10. Respiratory Tract Infection Bacterial: 5 people, 11.63%

* Approximation only. Some reports may have incomplete information.

Do you take Zosyn and Macrobid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zosyn and Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macrobid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on piperacillin sodium; tazobactam sodium and nitrofurantoin; nitrofurantoin, macrocrystalline (the active ingredients of Zosyn and Macrobid, respectively), and Zosyn and Macrobid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: